In this free webinar, learn the importance of capturing Clinical Outcome Assessment (COA) data and what global regulators require. Attendees will gain insight into the impact of paper diaries and electronic diaries on trial data quality, timelines and cost. The featured speakers will discuss what a decentralized or hybrid trial is and how this impacts COA collection along with why real-time data is valuable in early phase clinical trials.
TORONTO, Oct. 13, 2022 /PRNewswire-PRWeb/ -- In this webinar, a team of expert panelists will answer key questions around the importance of Clinical Outcome Assessment (COA) data in early phase trials. They'll take a deep dive into frequently asked questions around effective COA collection strategies including the debate between paper vs. electronic diaries, electronic COA (eCOA) collection in decentralized and hybrid trials, regulatory requirements and guidance on patient-reported data, benefits of real-time data access and more!
Learn from industry authorities as they explore issues which impact data quality and patient burden for biotechs, pharma and CROs.
Join Donna L. Reed, Consultant to the pharma industry; Bryan McDowell, MSc, MBA, Vice President, eCOA Clinical Science & Consulting; Kelly Dumais, PhD, Principal Scientific Advisor; and Chris Vogel (webinar moderator), Executive Director, eCOA Solutions, Clario, for the live webinar on Friday, October 28, 2022, at 9:30am EDT (3:30pm CEST/EU-Central).
For more information, or to register for this event, visit How to Optimize Patient and Clinician Outcome Assessment Data (COA) in Early Phase Clinical Trials.
ABOUT CLARIO
Clario is a leading technology company that generates the richest clinical evidence in the industry for our pharmaceutical, biotech and medical device partners. Across decentralized and site-based trials, our deep scientific expertise, global scale and the broadest endpoint technology platform in the industry allow our partners to transform lives. Clario's Trial Anywhere™ solutions have been powering hybrid and decentralized clinical trials (DCT) for over 20 years, enabling sponsors to collect high-quality endpoint data from any modality or location, all while improving patient experience and diversity. Clario has the only technology platform that combines eCOA, cardiac safety, medical imaging, precision motion and respiratory endpoints. With 30 facilities in nine countries, Clario's global team of science, technology and operational experts has helped deliver over 19,000 trials and 870 regulatory for over 5m patients in 120 countries. Our innovation has been transforming clinical trials for 50 years.
For more information, go to Clario.com or follow us on LinkedIn and Twitter.
Clario Media Contact
Duncan Cantor
Sr. Director, Corporate Communications
[email protected]
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
Share this article